Orantinib
3-[2,4-dimethyl-5-[(E)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid
Also Known As: Orantinib|Orantinibum|Orantinib [INN]|TSU-68|TSU 68|SU 6668|TSU-68 (SU6668,Orantinib)|QCR-161|SU-6668|TSU-68;SU-6668|3-[2,4-dimethyl-5-[(E)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid|SU6668|AN-3593|EX-8599|(E)-3-(2,4-dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid|BRD-K91696562-001-01-8|2,4-DIMETHYL-5-[ METHYL]-PYRROLE-3-PROPANOICACID|3-[2,4-dimethyl-5-[(E)-(2-oxo-1H-indol-3-ylidene)m|3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid|3-[2,4-dimethyl-5-[(E)-(2-oxoindolin-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid|5-((1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-propanoic acid|2,4-DIMETHYL-5-[(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL]-PYRROLE-3-PROPANOICACID|3-(4-(2-Carboxyethyl)-3,5-dimethylpyrrol-2-methylidenyl)-2-indolinone|(Z)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)-methyl)-1H-pyrrol-3-yl)propanoic acid|2,4-dimethyl-5-[(1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]pyrrole-3-propanoic acid|3-(2,4-Dimethyl-5-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid|3-(2,4-Dimethyl-5-((2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-1H-pyrrol-3-yl)propionic acid
| Molecular Formula | C18H18N2O3 |
|---|---|
| Molecular Weight | 310.13174 g/mol |
| LogP | 3.14144 |
| Topological Polar Surface Area | 82.19 Ų |
| Hydrogen Bond Donors | 3 |
| Hydrogen Bond Acceptors | 2 |
| Rotatable Bonds | 4 |
| Exact Mass | 310.13174 |
| Monoisotopic Mass | 310.13174 |
| Heavy Atoms | 23 |
| Complexity | 830.7874 |
Chemical Identifiers
| CAS Number | 210644-62-5 |
|---|---|
| SMILES | CC1=C(NC(=C1CCC(=O)O)C)/C=C/2\C3=CC=CC=C3NC2=O |
Product Overview
Orantinib (CAS 210644-62-5), with molecular formula C18H18N2O3 and molecular weight 310.13174 g/mol. IUPAC: 3-[2,4-dimethyl-5-[(E)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid.